BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27717886)

  • 21. Tibolone Effects on Human Glioblastoma Cell Lines.
    González-Arenas A; De la Fuente-Granada M; Camacho-Arroyo I; Zamora-Sánchez CJ; Piña-Medina AG; Segura-Uribe J; Guerra-Araiza C
    Arch Med Res; 2019 May; 50(4):187-196. PubMed ID: 31499479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
    Lee O; Choi MR; Christov K; Ivancic D; Khan SA
    Cancer Lett; 2016 Jul; 376(2):310-7. PubMed ID: 27080304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The progesterone receptor antagonist mifepristone does not lower serum progesterone induced blocking factor (PIBF) in the presence of progesterone.
    Check JH; DiAntonio G; DiAntonio A; Duroseau M
    Clin Exp Obstet Gynecol; 2016; 43(2):189-91. PubMed ID: 27132407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of progesterone in human astrocytomas growth.
    Cabrera-Muñoz E; Hernández-Hernández OT; Camacho-Arroyo I
    Curr Top Med Chem; 2011; 11(13):1663-7. PubMed ID: 21463255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5alpha-dihydroprogesterone promotes proliferation and migration of human glioblastoma cells.
    Zamora-Sánchez CJ; Hernández-Vega AM; Gaona-Domínguez S; Rodríguez-Dorantes M; Camacho-Arroyo I
    Steroids; 2020 Nov; 163():108708. PubMed ID: 32730775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
    Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
    Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular Progesterone Receptor Mediates the Increase in Glioblastoma Growth Induced by Progesterone in the Rat Brain.
    Germán-Castelán L; Manjarrez-Marmolejo J; González-Arenas A; Camacho-Arroyo I
    Arch Med Res; 2016 Aug; 47(6):419-426. PubMed ID: 27986121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy-associated changes in expression of progesterone receptor and progesterone-induced blocking factor genes in bone marrow of ewes.
    Zhang LY; Mi H; Yan JK; Yan XX; Yang L
    Anim Reprod Sci; 2017 Nov; 186():77-84. PubMed ID: 28947097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells.
    Lin CW; Hou WC; Shen SC; Juan SH; Ko CH; Wang LM; Chen YC
    Carcinogenesis; 2008 Sep; 29(9):1807-15. PubMed ID: 18628248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progesterone receptor and SRC-1 participate in the regulation of VEGF, EGFR and Cyclin D1 expression in human astrocytoma cell lines.
    Hernández-Hernández OT; González-García TK; Camacho-Arroyo I
    J Steroid Biochem Mol Biol; 2012 Oct; 132(1-2):127-34. PubMed ID: 22542550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway.
    Uht RM; Amos S; Martin PM; Riggan AE; Hussaini IM
    Oncogene; 2007 May; 26(20):2885-93. PubMed ID: 17146445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histamine increases sphingosine kinase-1 expression and activity in the human arterial endothelial cell line EA.hy 926 by a PKC-alpha-dependent mechanism.
    Huwiler A; Döll F; Ren S; Klawitter S; Greening A; Römer I; Bubnova S; Reinsberg L; Pfeilschifter J
    Biochim Biophys Acta; 2006 Mar; 1761(3):367-76. PubMed ID: 16571380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progesterone-induced blocking factor (PIBF) and trophoblast invasiveness.
    Miko E; Halasz M; Jericevic-Mulac B; Wicherek L; Arck P; Arató G; Skret Magierlo J; Rukavina D; Szekeres-Bartho J
    J Reprod Immunol; 2011 Jun; 90(1):50-7. PubMed ID: 21632119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues.
    Lin VC; Aw SE; Ng EH; Ng EH; Tan MG
    Br J Cancer; 2001 Dec; 85(12):1978-86. PubMed ID: 11747343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein kinase Calpha and protein kinase Cdelta play opposite roles in the proliferation and apoptosis of glioma cells.
    Mandil R; Ashkenazi E; Blass M; Kronfeld I; Kazimirsky G; Rosenthal G; Umansky F; Lorenzo PS; Blumberg PM; Brodie C
    Cancer Res; 2001 Jun; 61(11):4612-9. PubMed ID: 11389098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
    Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
    Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells.
    Li M; Zhao D; Ma G; Zhang B; Fu X; Zhu Z; Fu L; Sun X; Dong JT
    Biochem Biophys Res Commun; 2013 Jan; 430(1):358-63. PubMed ID: 23159610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LPA
    Valdés-Rives SA; de la Fuente-Granada M; Velasco-Velázquez MA; González-Flores O; González-Arenas A
    Int J Biochem Cell Biol; 2019 May; 110():91-102. PubMed ID: 30849522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of FGFR2b expression and signaling in keratinocyte differentiation: sequential involvement of PKCδ and PKCα.
    Rosato B; Ranieri D; Nanni M; Torrisi MR; Belleudi F
    Cell Death Dis; 2018 May; 9(5):565. PubMed ID: 29752438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
    Wen-Sheng W
    Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.